Navigation Links
MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting

ntage of patients who were emesis-free was numerically higher in the 10 mcg/kg group; however, as with CR, these differences were primarily seen in children less than 2 years. A numerically higher proportion of patients (aged 6-17 years) with no nausea was also observed in the 10 mcg/kg group. Both doses showed a similar time to treatment failure (time to first emetic episode and/or first administration of rescue medication). The pharmacokinetic data show that total body clearance and volume of distribution of Aloxi increased with age-related body weight, as expected. The long half-life (21-37 hours) of Aloxi in this pediatric population was consistent with that in adults. There were no cardiac safety concerns or serious treatment related adverse events.

Dacogen(R) for Injection

Study of Response to Dacogen in Older Patients Diagnosed with Acute Myelogenous Leukemia (AML)

The impact of Dacogen on the survival of older patients with AML was presented in a poster discussion on Monday, June 4, 2007. A total of 33 patients meeting the WHO definition of AML ( greater than or equal to20% bone marrow blasts) who had been treated with Dacogen as front-line therapy on either the randomized Phase 3 study in patients with myelodysplastic syndromes, or on two consecutive studies of Dacogen, alone or in combination with valproic acid were evaluated retrospectively. Response to therapy was assessed by the International Working Group criteria. In the 33 patients treated with intravenous Dacogen (100-150 mg/m2/course), an overall response rate ranging from 50-57% was observed across the three clinical trials with complete and partial response rates of 24% and 6%, respectively, and hematologic improvement and marrow complete response rates of 15% and 6%, respectively. The median survival for the Dacogen treated patients was

12.6 months, the median duration of response was 8.8 months, and 1- and 2-year survival rates were 51% and 26%, respectively. Regardl
'"/>




Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Sygnis Pharma AG announces date for presentation of clinical results
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
Post Your Comments:
(Date:5/21/2015)...  CryoLife, Inc. (NYSE: CRY ), a leading ... and vascular surgery, announced today that its Board of ... second quarter 2015 of $0.03 per share of common ... share will be paid on June 19, 2015 to ... 2015.  The ex-dividend date for the quarterly dividend is ...
(Date:5/21/2015)... , May 21, 2015  (MUSE Booth ... Electronic Health Record (EHR) is invaluable in any ... EHRs are now a requirement and mainstream in ... continuously into the EHR is gaining traction in ... William Holmes, RN, Site Project Manager & Clinical ...
(Date:5/21/2015)... , 21. Mai 2015 ... ), ein Unternehmen für Arzneimittel im ... Entwicklung und Vermarktung von Locilex® (Pexiganan-Creme ... heute eine wissenschaftliche Posterpräsentation an, welche ... Unternehmens vorstellt, OneStep-1 und OneStep-2, in ...
Breaking Medicine Technology:CryoLife Announces Quarterly Cash Dividend for the Second Quarter 2015 2Hospital Streamlines ICU Efficiency with Timely Data Integration 2Hospital Streamlines ICU Efficiency with Timely Data Integration 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 4Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 5Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 6Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 7
... June 15 Halt Medical, Inc., today announced that the ... Electrosurgical System for soft tissue ablation using radiofrequency energy.  "This clearance ... investors," said Russ DeLonzor , President and Chief Operating Officer.  ... Radiofrequency ...
... WAYNE, N.J. , June 15 Today, Bayer HealthCare ... Inc., Barr Pharmaceuticals LLC, and Barr Laboratories, Inc. in the Northern ... and patent infringement in connection with Teva,s generic oral contraceptive, Gianvi™. ... leading oral contraceptive YAZ ® .   , ...
Cached Medicine Technology:Halt Medical, Inc. Receives FDA Clearance 2Bayer Sues Teva and Barr for False Advertising and Patent Infringement in Connection with Teva's Generic Oral Contraceptive Gianvi™ 2Bayer Sues Teva and Barr for False Advertising and Patent Infringement in Connection with Teva's Generic Oral Contraceptive Gianvi™ 3Bayer Sues Teva and Barr for False Advertising and Patent Infringement in Connection with Teva's Generic Oral Contraceptive Gianvi™ 4Bayer Sues Teva and Barr for False Advertising and Patent Infringement in Connection with Teva's Generic Oral Contraceptive Gianvi™ 5
(Date:5/23/2015)... 23, 2015 Javon Bea Mercy ... Sports Medicine and Rehabilitation Center, 557 N. Washington St., ... June 1-July 20, 5:30-6:30 pm. , The 8-week clinic ... Laurie Finke, RN, BSN, who will offer training that ... nutrition, running mechanics and show selection and weekly training ...
(Date:5/22/2015)... May 22, 2015 The world ... and capacity are intersecting to create new opportunities ... the opening speaker at WesternU's 34th annual Commencement ... Gov. Gavin Newsom, a former San Francisco mayor ... speaker at the graduation ceremony for WesternU's colleges ...
(Date:5/22/2015)... Mountain Point Medical Center, a campus of ... on Friday, May 29, 2015 at 11 a.m., followed by ... new medical center, set to officially open on June 1, ... 84043. , “The opening of Mountain Point Medical Center ... County community,” said Kent Loosle, CEO of Mountain Point Medical ...
(Date:5/22/2015)... May 22, 2015 Following yesterday’s announcement ... agreement with US-based health brand Nature’s Way, Marc St-Onge ... Retention of Ascenta Skin is an integral part of ... about this opportunity to further develop Ascenta Skin into ... Ascenta Skin is a breakthrough, anti-aging skincare supplement featuring ...
(Date:5/22/2015)... Island, NY (PRWEB) May 22, 2015 ... announces that June 17, 2015, the Annual One Day ... place. Since 2007, Hands On HCMT offers drastically reduced certificates ... therapists and estheticians have enough sessions, through what used to ... it is wonderful for the community as well. This once ...
Breaking Medicine News(10 mins):Health News:Newsom to WesternU Grads: The Future is Inside You 2Health News:Newsom to WesternU Grads: The Future is Inside You 3Health News:Mountain Point Medical Center, a Campus of Jordan Valley Medical Center, Hosts Ribbon Cutting Ceremony and Community Celebration on Friday, May 29, 2015 2Health News:Ascenta Skin President Announces Plans to Grow Brand 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 3
... set by drug traffickers, a new breed of tobacco ... be affected soon, a top official //of the World ... international drug cartels have some links with terrorists but ... with terrorist outfits. Security agencies in the European Union ...
... of men in western cultures are affected by Obstructive ... OSA experience more harmful //psychological symptoms than people with ... of Forensic Sciences. ,Sex offenders with ... Airway Pressure(CPAP), whereby compressed air is applied into the ...
... disease that is preventable and curable, yet every 30 seconds ... posed one of the biggest challenges //to healthcare experts and ... a punch through an innocuous looking mite. It is apt ... proud much before the unique selling 'Made in China' tag, ...
... called as 'Black Disease' as commented by Phill Wilson, executive ... is because of the growing AIDS population among the blacks, ... across the country. African-Americans comprise 13% of the total population ... prone to disease 10 times more than the whites. ...
... research suggests that testosterone replacement therapy for men with ... the prostate gland, contrary to some reports that this ... the November 15 issue of JAMA, a theme issue ... of the Urological Sciences Research Foundation and University of ...
... who received a combination therapy were more likely to report ... according to a study in the November 15 issue of ... ,Steven A. Kaplan, M.D., of Weill Cornell Medical College, New ... JAMA media briefing on men's health in New York. ...
Cached Medicine News:Health News:Tobacco Smugglers are Helping Terrorists: WHO 2Health News:Malaria: The Invincible Might of a Parasite, Nestled in a 'Mite' 2Health News:Malaria: The Invincible Might of a Parasite, Nestled in a 'Mite' 3Health News:Testosterone Replacement Therapy Appears Safe for Prostate 2Health News:Combination Therapy More Effective for Treating Lower Urinary Tract Symptoms 2
... technology allow the incredible sharpness of diamonds ... cost. Proven diamond blade sharpness improves stromal ... postoperative result. The knives offer unlimited uses, ... widths and configurations. The diamonds are available ...
... Toyos Aqua-Chopper, Is Used In The Subordinate ... Aqualase Cataract Removal As Well As Standard ... Allows Easy Manipulation At The Incision Site Without ... Safe Sweeping Of Nuclear Material Away From ...
... Can Be Set To Any Degree Interval For ... 14mm Outer Diameter Opposing Radials Accommodate All Astigmatic ... Set For AKs, LRIs Or Peripheral Corneal Incisions ... Or Paired AKs, LRIs Or Peripheral Corneal Incisions ...
... Unique Reversible Speculums Designed To ... By Flipping The Speculums Over, Allowing ... Palpebral Fissures To The Widest Possible ... Operation, Providing Unobstructed Around-The-Clock Access To ...
Medicine Products: